B-cell activating factor receptor (BAFF-R) chimeric antigen receptor (CAR) T-cell therapy incited cytotoxic effects on both ...

Harnessing the body's B-cells to fight tumors may be a promising treatment for glioblastoma, according to a Northwestern ...

Changes in the production of several immune proteins at the time of an ALS diagnosis were linked to disease progression in ...

University of Rochester researchers have demonstrated a noninvasive method using BL-OG, or bioluminescent optogenetics, that ...

The introduction of clustered enhancing mutations led to complement activation by anti-capsule antibodies for both K.

Researchers have developed a noninvasive method called bioluminescent optogenetics (BL-OG), which uses light to activate neurons in the brain without the need for implanted devices.

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimm ...

Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...

Researchers identified a new mechanism in the DNA damage response involving the long non-coding RNA NEAT1. Increased NEAT1 ...

Proper storage and shipping conditions for cell and gene therapy products are crucial for the design, repeatability, and ...

Casitas B-lineage lymphoma b (Cbl/b) is an E3 ubiquitin ligase that has been shown to be a key regulator of the activation of T and natural killer (NK) cells in the absence of CD28 costimulation GRC ...

Title: Therapeutic potential of CAN-3110 in Ras-Raf pathway altered melanoma Presenter: Anne Diers, PhD, Senior Director, Research, Candel Therapeutics Abstract Number: 995 Session Date: Friday, Nov.